https://medicaex.com/businesswire/momentum-at-south-bay-for-rehabilitation-and-nursing-earns-industry-quality-award-2/ 2022-11-30T21:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/Momentum_logo-W78UBf.jpeg https://medicaex.com/businesswire/quidelortho-to-host-investor-day-on-december-13-2022/ 2022-11-30T21:12:05+00:00 https://medicaex.com/businesswire/aurinia-announces-the-great-britain-marketing-authorization-of-lupkynis-voclosporin-for-the-treatment-of-lupus-nephritis/ 2022-11-30T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/aurina_logo-QRVOAl.jpeg https://medicaex.com/businesswire/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022/ 2022-11-30T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/exelixis_id_rgb_2c-o8cUOo.jpeg https://medicaex.com/businesswire/aura-biosciences-announces-proposed-public-offering-of-common-stock/ 2022-11-30T21:12:04+00:00 https://medicaex.com/businesswire/iveric-bio-announces-proposed-offering-of-common-stock/ 2022-11-30T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Iveric_Bio_Logo-kwhNDB.jpeg https://medicaex.com/businesswire/marinus-pharmaceuticals-announces-presentations-and-investor-event-at-american-epilepsy-society-2022-annual-meeting/ 2022-11-30T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/marinus-color-5788Gw.jpeg https://medicaex.com/businesswire/momentum-at-south-bay-for-rehabilitation-and-nursing-earns-industry-quality-award/ 2022-11-30T21:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Momentum_logo-6uhPt0.jpeg https://medicaex.com/businesswire/botanical-solution-inc-bsi-croda-pharma-partnership-agreement-to-accelerate-production-for-gmp-qs-21-2/ 2022-11-30T20:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Croda_Pharma_team_with_BSI_CEO_Gaston_Salinas-VFD9q5.jpeg https://medicaex.com/businesswire/botanical-solution-inc-bsi-croda-pharma-partnership-agreement-to-accelerate-production-for-gmp-qs-21/ 2022-11-30T20:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Croda_Pharma_team_with_BSI_CEO_Gaston_Salinas-LcGZ4B.jpeg https://medicaex.com/businesswire/nowrxs-pharmacy-patient-business-acquired-by-alto-pharmacy-4/ 2022-11-30T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/download-fySM46.jpeg https://medicaex.com/businesswire/everest-group-recognizes-softserve-as-a-key-player-in-digital-services-within-the-life-sciences-landscape-3/ 2022-11-30T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/B8D4D427-7198-4E45-92D3-57A87861B567_4_5005_c-BEYNIc.jpeg https://medicaex.com/businesswire/additional-us-4-million-received-for-next-development-steps-of-medincells-6-month-active-injectable-bioresorbable-subcutaneous-contraceptive-3/ 2022-11-30T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Logo_MedinCell_registered-kSZZI5.jpeg https://medicaex.com/businesswire/memgen-reports-results-from-its-first-in-human-clinical-trial-of-mem-288-in-solid-tumors-refractory-to-checkpoint-inhibitors-at-sitc-2022-2/ 2022-11-30T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Memgen_Logo_2022-04-28-ahsc1s.jpeg https://medicaex.com/businesswire/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada-2/ 2022-11-30T18:12:07+00:00 https://medicaex.com/businesswire/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada/ 2022-11-30T18:12:06+00:00 https://medicaex.com/businesswire/everest-group-recognizes-softserve-as-a-key-player-in-digital-services-within-the-life-sciences-landscape-2/ 2022-11-30T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/B8D4D427-7198-4E45-92D3-57A87861B567_4_5005_c-9ZlcCv.jpeg https://medicaex.com/businesswire/additional-us-4-million-received-for-next-development-steps-of-medincells-6-month-active-injectable-bioresorbable-subcutaneous-contraceptive-2/ 2022-11-30T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/Logo_MedinCell_registered-4OLjcq.jpeg https://medicaex.com/businesswire/nowrxs-pharmacy-patient-business-acquired-by-alto-pharmacy-3/ 2022-11-30T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/download-omLXOm.jpeg https://medicaex.com/businesswire/nowrxs-pharmacy-patient-business-acquired-by-alto-pharmacy-2/ 2022-11-30T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/download-I4QrbO.jpeg https://medicaex.com/businesswire/everest-group-recognizes-softserve-as-a-key-player-in-digital-services-within-the-life-sciences-landscape/ 2022-11-30T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/B8D4D427-7198-4E45-92D3-57A87861B567_4_5005_c-NcDrrP.jpeg https://medicaex.com/businesswire/additional-us-4-million-received-for-next-development-steps-of-medincells-6-month-active-injectable-bioresorbable-subcutaneous-contraceptive/ 2022-11-30T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Logo_MedinCell_registered-XrVwrO.jpeg https://medicaex.com/businesswire/memgen-reports-results-from-its-first-in-human-clinical-trial-of-mem-288-in-solid-tumors-refractory-to-checkpoint-inhibitors-at-sitc-2022/ 2022-11-30T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Memgen_Logo_2022-04-28-hnjwK4.jpeg https://medicaex.com/businesswire/nowrxs-pharmacy-patient-business-acquired-by-alto-pharmacy/ 2022-11-30T18:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/12/download-0vOulU.jpeg https://medicaex.com/businesswire/orthopedic-merger-acquisition-tracker-report-2022-raw-data-for-500-transactions-going-back-to-1993-researchandmarkets-com/ 2022-11-30T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-8gmPmC.jpeg https://medicaex.com/businesswire/spirita-oncology-llc-initiates-a-phase-1-clinical-trial-of-the-anti-cancer-agent-e6201-in-combination-with-dabrafenib-in-patients-with-central-nervous-system-metastases-from-braf-v600-mutated-metast-2/ 2022-11-30T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/SPIRITA_Logo_Transparent_Background-HB21cq.jpeg https://medicaex.com/businesswire/crispr-and-cas-genes-market-report-2022-growing-need-for-novel-therapeutics-boosts-sector-researchandmarkets-com-2/ 2022-11-30T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-M79tSp.jpeg https://medicaex.com/businesswire/medical-alert-systems-global-market-report-2022-possibilities-of-integrating-smart-home-systems-with-the-device-to-ensure-better-operation-presents-opportunities-researchandmarkets-com-3/ 2022-11-30T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-IZjSoj.jpeg https://medicaex.com/businesswire/biosimilar-therapeutic-peptides-global-market-report-2022-featuring-eli-lilly-sanofi-amgen-pfizer-merck-more-researchandmarkets-com-2/ 2022-11-30T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-fz4cG8.jpeg https://medicaex.com/businesswire/digital-therapeutics-global-market-report-2022-growing-demand-for-personalised-medicine-bolsters-sector-researchandmarkets-com-3/ 2022-11-30T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-Y3kRBW.jpeg https://medicaex.com/businesswire/ge-healthcares-air-recon-dl-technology-recognized-by-popular-science-magazine-in-the-best-of-whats-new-awards-3/ 2022-11-30T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/ARDL_illustration_2800229-HesNvn.jpeg https://medicaex.com/businesswire/digital-therapeutics-global-market-report-2022-growing-demand-for-personalised-medicine-bolsters-sector-researchandmarkets-com-2/ 2022-11-30T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-Bwq1hP.jpeg https://medicaex.com/businesswire/medical-alert-systems-global-market-report-2022-possibilities-of-integrating-smart-home-systems-with-the-device-to-ensure-better-operation-presents-opportunities-researchandmarkets-com/ 2022-11-30T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-sO93N9.jpeg https://medicaex.com/businesswire/ge-healthcares-air-recon-dl-technology-recognized-by-popular-science-magazine-in-the-best-of-whats-new-awards-2/ 2022-11-30T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/ARDL_illustration_2800229-ESsKmA.jpeg https://medicaex.com/businesswire/medical-alert-systems-global-market-report-2022-possibilities-of-integrating-smart-home-systems-with-the-device-to-ensure-better-operation-presents-opportunities-researchandmarkets-com-2/ 2022-11-30T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-Y3R4ts.jpeg https://medicaex.com/businesswire/digital-therapeutics-global-market-report-2022-growing-demand-for-personalised-medicine-bolsters-sector-researchandmarkets-com/ 2022-11-30T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-AYgrJg.jpeg https://medicaex.com/businesswire/ge-healthcares-air-recon-dl-technology-recognized-by-popular-science-magazine-in-the-best-of-whats-new-awards/ 2022-11-30T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/ARDL_illustration_2800229-wrVkW6.jpeg https://medicaex.com/businesswire/spirita-oncology-llc-initiates-a-phase-1-clinical-trial-of-the-anti-cancer-agent-e6201-in-combination-with-dabrafenib-in-patients-with-central-nervous-system-metastases-from-braf-v600-mutated-metasta/ 2022-11-30T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/SPIRITA_Logo_Transparent_Background-Szffvg.jpeg https://medicaex.com/businesswire/crispr-and-cas-genes-market-report-2022-growing-need-for-novel-therapeutics-boosts-sector-researchandmarkets-com/ 2022-11-30T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-QMw6d0.jpeg https://medicaex.com/businesswire/biosimilar-therapeutic-peptides-global-market-report-2022-featuring-eli-lilly-sanofi-amgen-pfizer-merck-more-researchandmarkets-com/ 2022-11-30T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-cdDCbN.jpeg https://medicaex.com/businesswire/us-pet-market-report-2022-increasing-adoption-of-e-commerce-in-pet-care-products-drives-growth-researchandmarkets-com/ 2022-11-30T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-6X62IX.jpeg https://medicaex.com/businesswire/ptp-achieves-aws-level-1-managed-security-service-provider-competency-status/ 2022-11-30T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/PTP-New-Horizontal-Color-ElgtAE.jpeg https://medicaex.com/businesswire/relief-mental-health-opens-in-red-bank-to-provide-tms-esketamine-and-other-treatments-for-individuals-struggling-with-mental-health-diagnoses-2/ 2022-11-30T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/ReliefMentalHealth_filledbrain_Stacked-MkB5io.jpeg https://medicaex.com/businesswire/wellsky-partners-with-catholic-charities-of-southeast-michigan-to-improve-health-equity-and-outcomes/ 2022-11-30T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/WellSky_Aligned_Color-jPgUq5.jpeg https://medicaex.com/businesswire/leantaas-announces-december-transform-hospital-operations-virtual-summit-in-partnership-with-beckers-healthcare-2/ 2022-11-30T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/LeanTaaS_Main_Logo_Tagline_2-CYLYU1.jpeg https://medicaex.com/businesswire/adapthealth-to-participate-in-bofa-securities-home-care-conference-3/ 2022-11-30T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/adapthealth_greenblue_LOGO-xPLsU6.jpeg https://medicaex.com/businesswire/global-needles-market-report-2022-expanding-injectables-market-presents-lucrative-opportunities-researchandmarkets-com/ 2022-11-30T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-afCykr.jpeg https://medicaex.com/businesswire/adapthealth-to-participate-in-bofa-securities-home-care-conference-2/ 2022-11-30T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/adapthealth_greenblue_LOGO-xCvfBT.jpeg https://medicaex.com/businesswire/adapthealth-to-participate-in-bofa-securities-home-care-conference/ 2022-11-30T16:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/adapthealth_greenblue_LOGO-YUzSzr.jpeg https://medicaex.com/businesswire/global-ampoules-and-vials-market-report-2022-robust-growth-in-the-healthcare-and-pharmaceutical-industries-drives-sector-researchandmarkets-com-2/ 2022-11-30T16:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-DnzdsO.jpeg https://medicaex.com/businesswire/global-ampoules-and-vials-market-report-2022-robust-growth-in-the-healthcare-and-pharmaceutical-industries-drives-sector-researchandmarkets-com/ 2022-11-30T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-5lx0mS.jpeg https://medicaex.com/businesswire/relief-mental-health-opens-in-red-bank-to-provide-tms-esketamine-and-other-treatments-for-individuals-struggling-with-mental-health-diagnoses/ 2022-11-30T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/ReliefMentalHealth_filledbrain_Stacked-0wKKHU.jpeg https://medicaex.com/businesswire/antiviral-drugs-global-market-report-2022-increased-rd-efforts-from-key-players-to-fuel-future-growth-researchandmarkets-com/ 2022-11-30T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-4DDdJa.jpeg https://medicaex.com/businesswire/leantaas-announces-december-transform-hospital-operations-virtual-summit-in-partnership-with-beckers-healthcare/ 2022-11-30T16:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/LeanTaaS_Main_Logo_Tagline_2-yzDPQS.jpeg https://medicaex.com/businesswire/nimble-therapeutics-names-pete-gough-as-chief-scientific-officer-2/ 2022-11-30T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/nimble-therapeutics-logo-corporate-vertical-dZPKqt.jpeg https://medicaex.com/businesswire/celularity-ceo-robert-j-hariri-m-d-ph-d-addresses-fii-conference-on-the-science-and-technology-for-extending-healthy-human-lifespan/ 2022-11-30T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/celularity-horizontal-fullcolor-VGR2My.jpeg https://medicaex.com/businesswire/15th-annual-biotech-showcase-to-bring-global-life-science-executives-and-investors-back-in-person-for-investing-partnering-and-collaboration-3/ 2022-11-30T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/BTS_logo-FiLoba.jpeg https://medicaex.com/businesswire/dr-ravi-karra-joins-advanced-clinical-to-accelerate-global-growth-and-deliver-innovative-oncology-trials-2/ 2022-11-30T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/AC_-_Wordmark_Logo_-_HRZ_-_RGB-M6oxh6.jpeg https://medicaex.com/businesswire/utmb-and-hdt-bio-awarded-prototype-project-funding-worth-up-to-87-4m-from-the-u-s-government-to-develop-sarna-vaccine-technology-2/ 2022-11-30T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/UTMB_Health_PMS-300DPI28129_copylogo-uCdt8F.jpeg https://medicaex.com/businesswire/texas-am-university-mays-business-school-and-humana-announce-winners-of-sixth-annual-healthcare-analytics-case-competition/ 2022-11-30T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/HUM_logo-a6TKBb.jpeg https://medicaex.com/businesswire/global-remote-patient-monitoring-market-research-report-2022-growth-opportunities-in-ai-for-continuous-rpm-datasets-interoperability-and-transitional-and-home-care-researchandmarkets-com/ 2022-11-30T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-L0fKll.jpeg https://medicaex.com/businesswire/athenahealth-announces-clinical-advisory-board/ 2022-11-30T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/athenahealth_logo_RGB_primary-0ra3iv.jpeg https://medicaex.com/businesswire/melinta-therapeutics-optimizerx-announce-2022-innovate4outcomes-event/ 2022-11-30T15:12:05+00:00 https://medicaex.com/businesswire/utmb-and-hdt-bio-awarded-prototype-project-funding-worth-up-to-87-4m-from-the-u-s-government-to-develop-sarna-vaccine-technology/ 2022-11-30T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/UTMB_Health_PMS-300DPI28129_copylogo-BbwPrf.jpeg https://medicaex.com/businesswire/15th-annual-biotech-showcase-to-bring-global-life-science-executives-and-investors-back-in-person-for-investing-partnering-and-collaboration-2/ 2022-11-30T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/BTS_logo-48CnhU.jpeg https://medicaex.com/businesswire/dr-ravi-karra-joins-advanced-clinical-to-accelerate-global-growth-and-deliver-innovative-oncology-trials/ 2022-11-30T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/AC_-_Wordmark_Logo_-_HRZ_-_RGB-RnjeJ4.jpeg https://medicaex.com/businesswire/nimble-therapeutics-names-pete-gough-as-chief-scientific-officer/ 2022-11-30T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/nimble-therapeutics-logo-corporate-vertical-zecmiY.jpeg https://medicaex.com/businesswire/alternate-solutions-health-network-invests-in-its-digital-transformation-with-workato/ 2022-11-30T15:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Regular_28129-K8TooR.jpeg https://medicaex.com/businesswire/15th-annual-biotech-showcase-to-bring-global-life-science-executives-and-investors-back-in-person-for-investing-partnering-and-collaboration/ 2022-11-30T15:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/11/BTS_logo-BilyfP.jpeg https://medicaex.com/businesswire/livanova-to-present-scientific-data-at-american-epilepsy-society-2022-annual-meeting-3/ 2022-11-30T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/LN-Logo-Main-PANTONE-VGTfB6.jpeg https://medicaex.com/businesswire/carbon-health-announces-best-in-class-patient-outcomes-from-diabetes-program-2/ 2022-11-30T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/3_Up_CH_DiabetesProgram-6Lzycm.jpeg https://medicaex.com/businesswire/clarify-health-recognized-for-innovation-in-patient-recruitment-in-clinical-trials-2/ 2022-11-30T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Clarify-Health-Award-Logo_NPI-mwD2qE.jpeg https://medicaex.com/businesswire/propanc-biopharma-concludes-prp-could-become-an-effective-chemosensitizer-agent-against-pancreatic-cancer-2/ 2022-11-30T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/propanc-logo-SbD0Wt.jpeg https://medicaex.com/businesswire/philips-signs-research-agreement-to-explore-new-magnet-technologies-3/ 2022-11-30T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Philips_Logo-071HiD.jpeg https://medicaex.com/businesswire/audere-announces-the-appointment-of-dr-doris-macharia-to-board-of-directors/ 2022-11-30T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Doris_K_Macharia-3z3Xqg.jpeg https://medicaex.com/businesswire/livanova-to-present-scientific-data-at-american-epilepsy-society-2022-annual-meeting-2/ 2022-11-30T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/LN-Logo-Main-PANTONE-ilQoPh.jpeg https://medicaex.com/businesswire/philips-signs-research-agreement-to-explore-new-magnet-technologies-2/ 2022-11-30T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Philips_Logo-bSfFL7.jpeg https://medicaex.com/businesswire/livanova-to-present-scientific-data-at-american-epilepsy-society-2022-annual-meeting/ 2022-11-30T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/LN-Logo-Main-PANTONE-f57kiw.jpeg https://medicaex.com/businesswire/oligomerix-presents-data-from-ind-enabling-studies-on-clinical-candidate-at-clinical-trials-on-alzheimers-disease-ctad-and-neuroscience-2022-meetings/ 2022-11-30T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Oligomerix_logo-OCO6IM.jpeg https://medicaex.com/businesswire/philips-signs-research-agreement-to-explore-new-magnet-technologies/ 2022-11-30T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Philips_Logo-9BZbMd.jpeg https://medicaex.com/businesswire/carbon-health-announces-best-in-class-patient-outcomes-from-diabetes-program/ 2022-11-30T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/3_Up_CH_DiabetesProgram-0dv5y8.jpeg https://medicaex.com/businesswire/personalis-and-ucsf-to-study-clinical-utility-of-ctdna-for-treatment-response-in-colorectal-cancer/ 2022-11-30T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/PersonalisLogo-RGB-no-tagline-3mnCjz.jpeg https://medicaex.com/businesswire/new-advisory-brief-and-podcast-reveal-what-life-sciences-companies-need-to-know-to-be-prepared-for-2023/ 2022-11-30T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/trinity-logo-530_x_146-gTAVID.jpeg https://medicaex.com/businesswire/propanc-biopharma-concludes-prp-could-become-an-effective-chemosensitizer-agent-against-pancreatic-cancer/ 2022-11-30T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/propanc-logo-IZ4cCG.jpeg https://medicaex.com/businesswire/clarify-health-recognized-for-innovation-in-patient-recruitment-in-clinical-trials/ 2022-11-30T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Clarify-Health-Award-Logo_NPI-q5YcZz.jpeg https://medicaex.com/businesswire/harrow-and-ior-partners-expand-national-product-supply-agreement-3/ 2022-11-30T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Harrow_logo_wTag-jYqRKk.jpeg https://medicaex.com/businesswire/novo-integrated-sciences-subsidiary-clinical-consultants-international-signs-consulting-agreement-with-pharmaceutical-research-development-company-sarfez-pharmaceuticals-inc-5/ 2022-11-30T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/For_PRs_NVOS_Logo_28640x36029-kHCKeI.jpeg https://medicaex.com/businesswire/agilent-attains-angel-level-sponsorship-with-my-green-lab/ 2022-11-30T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Agilent_Logo_Tag_v_RGB-MHWkn7.jpeg https://medicaex.com/businesswire/ipas-subsidiary-biostrand-and-briacell-announce-artificial-intelligence-collaboration-and-license-agreement-to-discover-and-develop-anti-cancer-antibodies/ 2022-11-30T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/bria93-for_globenewswire-GARqpo.jpeg https://medicaex.com/businesswire/iecure-raises-65-million-to-advance-in-vivo-gene-editing-programs-for-the-treatment-of-rare-pediatric-liver-diseases/ 2022-11-30T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/iECURE_Logo_28229-9oAl0R.jpeg https://medicaex.com/businesswire/novo-integrated-sciences-subsidiary-clinical-consultants-international-signs-consulting-agreement-with-pharmaceutical-research-development-company-sarfez-pharmaceuticals-inc-4/ 2022-11-30T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/For_PRs_NVOS_Logo_28640x36029-IQyOUN.jpeg https://medicaex.com/businesswire/healthcare-mobility-solutions-market-analysis-by-mhealth-apps-mhealth-services-product-service-by-region-global-forecast-to-2029-researchandmarkets-com/ 2022-11-30T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Em2m1H.jpeg https://medicaex.com/businesswire/cera-makes-new-executive-hires-from-technology-leaders-deliveroo-amazon-and-just-eat-2/ 2022-11-30T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cera_Logo_PNG-H6l43V.jpeg https://medicaex.com/businesswire/eleven-ntt-papers-selected-for-neurips-2022/ 2022-11-30T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/NTTResearch_Symbol-JYGqr0.jpeg https://medicaex.com/businesswire/novo-integrated-sciences-subsidiary-clinical-consultants-international-signs-consulting-agreement-with-pharmaceutical-research-development-company-sarfez-pharmaceuticals-inc-3/ 2022-11-30T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/For_PRs_NVOS_Logo_28640x36029-dDLiao.jpeg https://medicaex.com/businesswire/neuropace-feasibility-study-of-its-rns-system-for-lennox-gastaut-syndrome-now-underway-2/ 2022-11-30T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/NeuroPace-Logo-Horiz-rgb-med-ivHON9.jpeg https://medicaex.com/businesswire/harrow-and-ior-partners-expand-national-product-supply-agreement-2/ 2022-11-30T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Harrow_logo_wTag-r6ML6V.jpeg https://medicaex.com/businesswire/neuropace-feasibility-study-of-its-rns-system-for-lennox-gastaut-syndrome-now-underway/ 2022-11-30T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/NeuroPace-Logo-Horiz-rgb-med-0upr20.jpeg https://medicaex.com/businesswire/clarametyx-initiates-phase-1-study-of-immune-enabling-antibody-therapy-cmtx-101-against-community-acquired-bacterial-pneumonia/ 2022-11-30T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Clarametyx_Logo-QG7vxP.jpeg https://medicaex.com/businesswire/harrow-and-ior-partners-expand-national-product-supply-agreement/ 2022-11-30T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Harrow_logo_wTag-YV2Lkb.jpeg https://medicaex.com/businesswire/novo-integrated-sciences-subsidiary-clinical-consultants-international-signs-consulting-agreement-with-pharmaceutical-research-development-company-sarfez-pharmaceuticals-inc-2/ 2022-11-30T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/For_PRs_NVOS_Logo_28640x36029-DiI9Lk.jpeg https://medicaex.com/businesswire/sengenics-broadens-its-systems-serology-tools-to-enable-the-detection-of-a-wider-range-of-autoantibody-biomarkers/ 2022-11-30T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/sengenics-logo-icon-tjJLDX.jpeg https://medicaex.com/businesswire/pivot-strengthens-commercial-leadership-with-new-vp-of-sales-and-vp-of-marketing/ 2022-11-30T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pivot_Standard_Logo-1.1_28129-8j7D3f.jpeg https://medicaex.com/businesswire/cera-makes-new-executive-hires-from-technology-leaders-deliveroo-amazon-and-just-eat/ 2022-11-30T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cera_Logo_PNG-8NdLFL.jpeg https://medicaex.com/businesswire/novo-integrated-sciences-subsidiary-clinical-consultants-international-signs-consulting-agreement-with-pharmaceutical-research-development-company-sarfez-pharmaceuticals-inc/ 2022-11-30T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/For_PRs_NVOS_Logo_28640x36029-w1CmTW.jpeg https://medicaex.com/businesswire/external-validation-confirms-included-health-navigation-offering-can-lower-healthcare-cost-trend-by-6-10-percentage-points-for-employers/ 2022-11-30T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Included_Logo_FullColor_Screen_28129-xDmzyM.jpeg https://medicaex.com/businesswire/puretech-announces-new-therapeutic-candidate-lyt-310-an-oral-form-of-cannabidiol-cbd-leveraging-puretechs-glyph-platform-3/ 2022-11-30T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/LYT310-Social_Graphic-yOzGRA.jpeg https://medicaex.com/businesswire/bluebird-bio-sells-priority-review-voucher-for-102-million-2/ 2022-11-30T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Full_Color_Logo_Bluebird-Logo-full-color-KxvclZ.jpeg https://medicaex.com/businesswire/pulmonx-receives-japanese-mhlw-approval-of-zephyr-endobronchial-valve-for-the-treatment-of-severe-copd-emphysema-2/ 2022-11-30T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/pulmonx_transparent_logo-FaNgEC.jpeg https://medicaex.com/businesswire/global-electronic-drug-delivery-systems-market-business-report-2022-a-16-3-billion-market-by-2027-with-wearable-infusion-pumps-accounting-for-6-7-billion-researchandmarkets-com/ 2022-11-30T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Py8AuO.jpeg https://medicaex.com/businesswire/ananda-scientific-announces-fda-approval-of-the-ind-for-a-clinical-trial-exploring-treatment-of-social-anxiety-disorder-sad-2/ 2022-11-30T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/MicrosoftTeams-image-RdUeFI.jpeg https://medicaex.com/businesswire/puretech-announces-new-therapeutic-candidate-lyt-310-an-oral-form-of-cannabidiol-cbd-leveraging-puretechs-glyph-platform-2/ 2022-11-30T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/LYT310-Social_Graphic-7uT1JM.jpeg https://medicaex.com/businesswire/nextgen-healthcare-announces-agreement-to-acquire-tsi-healthcare/ 2022-11-30T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/NG_Logo_Final_RGB_300-eWMTui.jpeg https://medicaex.com/businesswire/1-day-medical-device-industry-overview-training-course-clinical-research-medical-affairs-and-business-development-march-29-2023-researchandmarkets-com/ 2022-11-30T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-mhAiEh.jpeg https://medicaex.com/businesswire/pulmonx-receives-japanese-mhlw-approval-of-zephyr-endobronchial-valve-for-the-treatment-of-severe-copd-emphysema/ 2022-11-30T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/pulmonx_transparent_logo-aGIXKQ.jpeg https://medicaex.com/businesswire/astrazeneca-showcases-strength-of-hematology-portfolio-and-pipeline-across-multiple-hard-to-treat-conditions-at-ash-2022/ 2022-11-30T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-ks1FGh.jpeg https://medicaex.com/businesswire/analyzing-the-1-4-trillion-global-pharmaceutical-industry-2022-researchandmarkets-com/ 2022-11-30T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-yinZAt.jpeg https://medicaex.com/businesswire/puretech-announces-new-therapeutic-candidate-lyt-310-an-oral-form-of-cannabidiol-cbd-leveraging-puretechs-glyph-platform/ 2022-11-30T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/LYT310-Social_Graphic-ZUfn3S.jpeg https://medicaex.com/businesswire/bluebird-bio-sells-priority-review-voucher-for-102-million/ 2022-11-30T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Full_Color_Logo_Bluebird-Logo-full-color-C1Glu2.jpeg https://medicaex.com/businesswire/ananda-scientific-announces-fda-approval-of-the-ind-for-a-clinical-trial-exploring-treatment-of-social-anxiety-disorder-sad/ 2022-11-30T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/MicrosoftTeams-image-LF1xPH.jpeg https://medicaex.com/businesswire/viseon-inc-announces-preliminary-results-of-surgeon-experience-database-utilizing-maxview-system-during-minimally-invasive-lateral-spine-surgery-2/ 2022-11-30T11:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_no_tm-FWted4.jpeg https://medicaex.com/businesswire/nimbus-therapeutics-announces-positive-topline-results-for-phase-2b-clinical-trial-of-allosteric-tyk2-inhibitor-in-psoriasis-2/ 2022-11-30T11:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nimbus_logo_RGB_NoTM-wXKdGh.jpeg https://medicaex.com/businesswire/cell-counting-market-report-2022-growing-biotechnology-and-biopharmaceutical-industries-bolsters-growth-researchandmarkets-com/ 2022-11-30T11:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-NTPlpG.jpeg https://medicaex.com/businesswire/metagenomics-global-market-report-2022-featuring-agilent-technologies-f-hoffmann-la-roche-pacific-biosciences-of-california-more-researchandmarkets-com/ 2022-11-30T11:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-u2mljo.jpeg https://medicaex.com/businesswire/aurion-biotech-expands-its-leadership-team-2/ 2022-11-30T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sterling_Headshot_LinkedIn_28698x40029-Y24JLA.jpeg https://medicaex.com/businesswire/simplex-quantum-inc-completes-us-patent-registration-of-electrocardiogram-biometric-authentication-technology-2/ 2022-11-30T11:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/SIMPLEX_QUANTUM_Logo-cFRO7k.jpeg https://medicaex.com/businesswire/innovations-and-growth-opportunities-in-novel-diagnostics-monitoring-technologies-and-advanced-medical-devices-2022-researchandmarkets-com-2/ 2022-11-30T11:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Au6CR1.jpeg https://medicaex.com/businesswire/simplex-quantum-inc-completes-us-patent-registration-of-electrocardiogram-biometric-authentication-technology/ 2022-11-30T11:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/SIMPLEX_QUANTUM_Logo-fJdt34.jpeg https://medicaex.com/businesswire/viseon-inc-announces-preliminary-results-of-surgeon-experience-database-utilizing-maxview-system-during-minimally-invasive-lateral-spine-surgery/ 2022-11-30T11:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_no_tm-NhGDa9.jpeg https://medicaex.com/businesswire/innovations-and-growth-opportunities-in-novel-diagnostics-monitoring-technologies-and-advanced-medical-devices-2022-researchandmarkets-com/ 2022-11-30T11:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-IyYTLO.jpeg https://medicaex.com/businesswire/nimbus-therapeutics-announces-positive-topline-results-for-phase-2b-clinical-trial-of-allosteric-tyk2-inhibitor-in-psoriasis/ 2022-11-30T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nimbus_logo_RGB_NoTM-fYQ66A.jpeg https://medicaex.com/businesswire/aurion-biotech-expands-its-leadership-team/ 2022-11-30T11:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sterling_Headshot_LinkedIn_28698x40029-QDc8pk.jpeg https://medicaex.com/businesswire/2-day-medical-device-studies-training-course-regulatory-requirements-and-adverse-event-reporting-january-18-19-2023-researchandmarkets-com/ 2022-11-30T10:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-gj1OlX.jpeg https://medicaex.com/businesswire/surgical-sealants-adhesives-and-hemostats-global-market-forecast-to-2029-acquisitions-to-open-an-array-of-opportunities-for-the-market-to-flourish-researchandmarkets-com/ 2022-11-30T10:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-x4brKn.jpeg https://medicaex.com/businesswire/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies-4/ 2022-11-30T08:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/LabGenius_MoA_subs-oohKqi.jpeg https://medicaex.com/businesswire/perfect-day-expands-global-footprint-and-owned-manufacturing-capacity-in-india-2/ 2022-11-30T08:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/PD_Only_Mark_Black-e6IahQ.jpeg https://medicaex.com/businesswire/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies-3/ 2022-11-30T08:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/LabGenius_MoA_subs-MGRq47.jpeg https://medicaex.com/businesswire/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies-2/ 2022-11-30T08:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/LabGenius_MoA_subs-Q3iyqI.jpeg https://medicaex.com/businesswire/perfect-day-expands-global-footprint-and-owned-manufacturing-capacity-in-india/ 2022-11-30T08:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/PD_Only_Mark_Black-bGioSL.jpeg https://medicaex.com/businesswire/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies/ 2022-11-30T08:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/LabGenius_MoA_subs-eDY4Jp.jpeg https://medicaex.com/businesswire/agic-capital-acquires-majority-stake-in-atec-pharmatechnik-gmbh-2/ 2022-11-30T07:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/AGIC_logo-S5wJMA.jpeg https://medicaex.com/businesswire/sensorion-receives-orphan-drug-designation-for-otof-gt-for-the-treatment-of-otoferlin-gene-mediated-hearing-loss-from-the-us-food-and-drug-administration/ 2022-11-30T07:12:14+00:00 https://medicaex.com/businesswire/new-prospective-study-finds-that-masimo-sphb-noninvasive-and-continuous-hemoglobin-monitoring-can-help-provide-effective-blood-management-in-patients-undergoing-major-surgery-3/ 2022-11-30T07:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/RootSpHbPVi-Fqg949.jpeg https://medicaex.com/businesswire/new-prospective-study-finds-that-masimo-sphb-noninvasive-and-continuous-hemoglobin-monitoring-can-help-provide-effective-blood-management-in-patients-undergoing-major-surgery-2/ 2022-11-30T07:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/RootSpHbPVi-ycfaJK.jpeg https://medicaex.com/businesswire/new-prospective-study-finds-that-masimo-sphb-noninvasive-and-continuous-hemoglobin-monitoring-can-help-provide-effective-blood-management-in-patients-undergoing-major-surgery/ 2022-11-30T07:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/RootSpHbPVi-jP4xVC.jpeg https://medicaex.com/businesswire/agic-capital-acquires-majority-stake-in-atec-pharmatechnik-gmbh/ 2022-11-30T07:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/AGIC_logo-YvhU2K.jpeg https://medicaex.com/businesswire/otsuka-medical-devices-and-recor-medical-announce-submission-of-application-for-pre-market-approval-of-the-paradise-ultrasound-renal-denervation-urdn-system-to-the-u-s-food-and-drug-admini/ 2022-11-30T05:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Otsuka_logo-QrlRlV.jpeg https://medicaex.com/businesswire/recor-medical-and-otsuka-medical-devices-announce-submission-of-application-for-pre-market-approval-of-the-paradise-ultrasound-renal-denervation-urdn-system-to-the-u-s-food-and-drug-admini-3/ 2022-11-30T03:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/ReCor_logo-WWmWW0.jpeg https://medicaex.com/businesswire/recor-medical-and-otsuka-medical-devices-announce-submission-of-application-for-pre-market-approval-of-the-paradise-ultrasound-renal-denervation-urdn-system-to-the-u-s-food-and-drug-admini-2/ 2022-11-30T03:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/ReCor_logo-CjbPL4.jpeg https://medicaex.com/businesswire/recor-medical-and-otsuka-medical-devices-announce-submission-of-application-for-pre-market-approval-of-the-paradise-ultrasound-renal-denervation-urdn-system-to-the-u-s-food-and-drug-admini/ 2022-11-30T03:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/ReCor_logo-jyoY4G.jpeg https://medicaex.com/businesswire/alcon-prices-us1-3-billion-senior-notes-offering/ 2022-11-30T02:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alcon_CMYK_Tag-NsGC1M.jpeg https://medicaex.com/businesswire/rapid-dose-therapeutics-provides-update-on-failure-to-file-cease-trade-order-6/ 2022-11-29T23:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/RDT_LOGO-CKd2CX.jpeg https://medicaex.com/businesswire/rapid-dose-therapeutics-provides-update-on-failure-to-file-cease-trade-order-5/ 2022-11-29T23:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/RDT_LOGO-yKqFNG.jpeg https://medicaex.com/businesswire/horizon-therapeutics-plc-confirms-preliminary-discussions-regarding-potential-offer-2/ 2022-11-29T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Horizon_Logo_Full-Color_RGB_Registered_Logo-uC0Ayr.jpeg https://medicaex.com/businesswire/mirion-technologies-to-divest-biodex-physical-medicine/ 2022-11-29T22:12:05+00:00 https://medicaex.com/businesswire/horizon-therapeutics-plc-confirms-preliminary-discussions-regarding-potential-offer/ 2022-11-29T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Horizon_Logo_Full-Color_RGB_Registered_Logo-P7MVV1.jpeg https://medicaex.com/businesswire/kestra-medical-technologies-surpasses-100-million-covered-lives-for-assure-wearable-cardioverter-defibrillator-wcd-system/ 2022-11-29T20:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/kestra-medical-technologies-assure-wcd-system-1-nRXQGq.jpeg https://medicaex.com/businesswire/resilience-to-establish-a-biomanufacturing-partnership-with-astrazeneca-and-purchase-astrazenecas-manufacturing-site-in-west-chester-ohio-2/ 2022-11-29T19:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Resilience_Logotype_RGB_Black-FFp76j.jpeg https://medicaex.com/businesswire/resilience-to-establish-a-biomanufacturing-partnership-with-astrazeneca-and-purchase-astrazenecas-manufacturing-site-in-west-chester-ohio/ 2022-11-29T19:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Resilience_Logotype_RGB_Black-T7h3RM.jpeg https://medicaex.com/businesswire/photonic-advances-enhance-imaging-techniques-2/ 2022-11-29T18:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/foundation_logo-HzqdCR.jpeg https://medicaex.com/businesswire/new-study-finds-amnioband-membrane-effectively-heals-venous-leg-ulcers-in-less-time-3/ 2022-11-29T18:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/MTF_FINAL_LOGO-SjHg26.jpeg https://medicaex.com/businesswire/lateral-flow-assays-global-market-report-2022-increasing-prevalence-of-infectious-diseases-spurs-growth-researchandmarkets-com-4/ 2022-11-29T18:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-JGVhdj.jpeg https://medicaex.com/businesswire/lazurite-and-hospital-for-special-surgery-announce-a-collaboration-agreement-focused-on-lazurites-arthrofree-wireless-surgical-camera-system-2/ 2022-11-29T18:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/AF_51028k29_5-8WauX9.jpeg https://medicaex.com/businesswire/new-study-finds-amnioband-membrane-effectively-heals-venous-leg-ulcers-in-less-time-2/ 2022-11-29T18:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/MTF_FINAL_LOGO-TUxSJn.jpeg https://medicaex.com/businesswire/lateral-flow-assays-global-market-report-2022-increasing-prevalence-of-infectious-diseases-spurs-growth-researchandmarkets-com-3/ 2022-11-29T18:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-gQg5gX.jpeg https://medicaex.com/businesswire/photonic-advances-enhance-imaging-techniques/ 2022-11-29T18:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/foundation_logo-Q5m4ED.jpeg https://medicaex.com/businesswire/lazurite-and-hospital-for-special-surgery-announce-a-collaboration-agreement-focused-on-lazurites-arthrofree-wireless-surgical-camera-system/ 2022-11-29T18:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/AF_51028k29_5-nYwDbr.jpeg https://medicaex.com/businesswire/lateral-flow-assays-global-market-report-2022-increasing-prevalence-of-infectious-diseases-spurs-growth-researchandmarkets-com-2/ 2022-11-29T18:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-pN2Jf1.jpeg https://medicaex.com/businesswire/new-study-finds-amnioband-membrane-effectively-heals-venous-leg-ulcers-in-less-time/ 2022-11-29T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/MTF_FINAL_LOGO-KKcBol.jpeg https://medicaex.com/businesswire/lateral-flow-assays-global-market-report-2022-increasing-prevalence-of-infectious-diseases-spurs-growth-researchandmarkets-com/ 2022-11-29T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-W8RbsT.jpeg https://medicaex.com/businesswire/oncology-precision-medicine-market-report-2022-gene-therapy-represents-lucrative-growth-opportunities-researchandmarkets-com/ 2022-11-29T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Naf7GF.jpeg https://medicaex.com/businesswire/vetter-hackathon-2022-innovation-booster-through-employee-participation-4/ 2022-11-29T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Die_Projektteams_diskutieren_ihre_AnsC3A4tze-L6GK7V.jpeg https://medicaex.com/businesswire/lysogene-provides-updates-and-topline-results-from-phase-2-3-aavance-gene-therapy-clinical-study-4/ 2022-11-29T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lysogene_-_Logo-vvmFGD.jpeg https://medicaex.com/businesswire/maat-pharma-to-webcast-investor-meeting-in-conjunction-with-ash-2022-conference-2/ 2022-11-29T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nov_2018_new_version_MaaT_Pharma_logo-PxUIbG.jpeg https://medicaex.com/businesswire/merck-announces-first-quarter-2023-dividend-2/ 2022-11-29T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Merck_Logo_Horizontal_Teal26Grey_RGB-PbYC4s.jpeg https://medicaex.com/businesswire/vetter-hackathon-2022-innovation-booster-through-employee-participation-3/ 2022-11-29T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Die_Projektteams_diskutieren_ihre_AnsC3A4tze-2gsnmy.jpeg https://medicaex.com/businesswire/vetter-hackathon-2022-innovation-booster-through-employee-participation-2/ 2022-11-29T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Die_Projektteams_diskutieren_ihre_AnsC3A4tze-jB3u0z.jpeg https://medicaex.com/businesswire/maat-pharma-to-webcast-investor-meeting-in-conjunction-with-ash-2022-conference/ 2022-11-29T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nov_2018_new_version_MaaT_Pharma_logo-5nXT0H.jpeg https://medicaex.com/businesswire/merck-announces-first-quarter-2023-dividend/ 2022-11-29T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Merck_Logo_Horizontal_Teal26Grey_RGB-hsUFtb.jpeg https://medicaex.com/businesswire/vetter-hackathon-2022-innovation-booster-through-employee-participation/ 2022-11-29T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Die_Projektteams_diskutieren_ihre_AnsC3A4tze-QDCC0h.jpeg https://medicaex.com/businesswire/lysogene-provides-updates-and-topline-results-from-phase-2-3-aavance-gene-therapy-clinical-study-3/ 2022-11-29T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lysogene_-_Logo-8uMeuv.jpeg https://medicaex.com/businesswire/pharmajet-receives-nih-grant-to-evaluate-use-of-needle-free-intradermal-delivery-for-hpv-immunization-4/ 2022-11-29T16:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/50-10057C_PJ_Trademark-MzBO99.jpeg https://medicaex.com/businesswire/biogennixs-directcell-advanced-bone-grafting-system-used-in-1000th-case-2/ 2022-11-29T16:12:11+00:00 https://medicaex.com/businesswire/c2n-diagnostics-introduces-the-precivityad2-blood-test-2/ 2022-11-29T16:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Picture1-vwHMd5.jpeg https://medicaex.com/businesswire/surgical-devices-pipeline-report-2022-includes-stages-of-development-segments-regions-countries-regulatory-path-and-key-companies-researchandmarkets-com/ 2022-11-29T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-inv7T4.jpeg https://medicaex.com/businesswire/pharmajet-receives-nih-grant-to-evaluate-use-of-needle-free-intradermal-delivery-for-hpv-immunization-3/ 2022-11-29T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/50-10057C_PJ_Trademark-kWiybV.jpeg https://medicaex.com/businesswire/ardent-health-services-and-biointellisense-launch-state-of-the-art-continuous-inpatient-monitoring-initiative-to-advance-care-and-optimize-workflow/ 2022-11-29T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ardent_logo_Color_2019-BaNwth.jpeg https://medicaex.com/businesswire/pharmajet-receives-nih-grant-to-evaluate-use-of-needle-free-intradermal-delivery-for-hpv-immunization-2/ 2022-11-29T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/50-10057C_PJ_Trademark-xorIQs.jpeg https://medicaex.com/businesswire/global-sterilization-equipment-industry-2027-increasing-number-of-medical-device-and-pharmaceutical-companies-in-emerging-economies-presents-opportunities-researchandmarkets-com/ 2022-11-29T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-HR37W3.jpeg https://medicaex.com/businesswire/pharmajet-receives-nih-grant-to-evaluate-use-of-needle-free-intradermal-delivery-for-hpv-immunization/ 2022-11-29T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/50-10057C_PJ_Trademark-DjsnBU.jpeg https://medicaex.com/businesswire/biogennixs-directcell-advanced-bone-grafting-system-used-in-1000th-case/ 2022-11-29T16:12:04+00:00 https://medicaex.com/businesswire/c2n-diagnostics-introduces-the-precivityad2-blood-test/ 2022-11-29T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Picture1-wX97OF.jpeg https://medicaex.com/businesswire/nexgen-biobanking-opens-in-gwinnett-county-bringing-crucial-biospecimen-storage-infrastructure-to-georgias-life-science-industry-4/ 2022-11-29T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/CGHI_Logo-1_RGB-W_300dpi_28329-bdru4n.jpeg https://medicaex.com/businesswire/gyros-protein-technologies-adds-gyrolab-biomarker-kits-to-expand-range-of-ready-to-use-kits-and-reagents-2/ 2022-11-29T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_GPT_2016_150_dpi_small-7xlAbc.jpeg https://medicaex.com/businesswire/nexgen-biobanking-opens-in-gwinnett-county-bringing-crucial-biospecimen-storage-infrastructure-to-georgias-life-science-industry-3/ 2022-11-29T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/CGHI_Logo-1_RGB-W_300dpi_28329-vUEb8e.jpeg https://medicaex.com/businesswire/caire-to-acquire-mgc-diagnostics-holdings-inc-2/ 2022-11-29T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/CAIRE_Inc._Logo-HelO7u.jpeg https://medicaex.com/businesswire/cubresa-announces-the-appointment-of-2-new-board-members-2/ 2022-11-29T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/cubresa_logo-dnn99o.jpeg https://medicaex.com/businesswire/onshift-adds-industry-leader-proliant-to-network-of-partners-for-payroll-hris/ 2022-11-29T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/On_Shift_logo_2c-oyu96O.jpeg https://medicaex.com/businesswire/soundbite-medical-solutions-announces-issuance-of-two-new-u-s-patent-further-expanding-coverage-of-its-shock-wave-technology/ 2022-11-29T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/sb_logo_coul_CMYK_uncoated_28129_highres-eeqDRG.jpeg https://medicaex.com/businesswire/global-airway-management-devices-market-forecast-report-2022-a-3-1-billion-market-by-2028-increase-in-rd-activities-and-collaborations-among-market-players-researchandmarkets-com/ 2022-11-29T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-TOdc2h.jpeg